Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer: A single-institute experience of 236 patients

Strahlentherapie und Onkologie

Volumn 181, Issue 12, 2005, Pages 762-767

  Strnad, Vratislav ^a   Melzner, Winfried ^a   Geiger, Matthias ^a   Zenk, Johannes ^a   Waldfahrer, Frank ^a   Lotter, Michael ^a   Ott, Oliver ^a   Seeger, Annedore ^a   Iro, Heinrich ^a   Sauer, Rolf ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Head and neck tumors; Pulsed dose rate brachytherapy

Indexed keywords

ARTICLE; BONE NECROSIS; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MOUTH CANCER; OROPHARYNX CANCER; RADIATION DOSE; TISSUE NECROSIS;

BRACHYTHERAPY; COMORBIDITY; DISEASE-FREE SURVIVAL; GERMANY; HUMANS; INCIDENCE; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RADIATION INJURIES; RISK ASSESSMENT; RISK FACTORS; SOFT TISSUE INJURIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 29144435950     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-005-1424-5     Document Type: Article

References (43)

1. Armour EP, White JR, Armin A, et al. Pulsed low dose rate brachytherapy in a rat model: dependence of late rectal injury on radiation pulse size. Int J Radiat Oncol Biol Phys 1997;38:825-34.
2. Beitler JJ, Smith RV, Silver CE, et al. Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Int J Radiat Oncol Biol Phys 1998;40:313-7.
3. Brenner DJ, Schiff PB, Huang Y, et al. Pulsed-dose-rate brachytherapy: design of convenient (daytime-only) schedules. Int J Radiat Oncol Biol Phys 1997;39:809-15.
4. Chao KS, Emami B, Akhileswaran R, et al. The impact of surgical margin status and use of an interstitial implant on T1, T2 oral tongue cancers after surgery. Int J Radiat Oncol Biol Phys 1996;36:1039-43.
5. Chen CZ, Huang Y, Hall EJ, et al. Pulsed brachytherapy as a substitute for continuous low dose rate: an in vitro study with human carcinoma cells. Int J Radiat Oncol Biol Phys 1997;37:137-43.
6. De Pree C, Popowski Y, Weber D, et al. Feasibility and tolerance of pulsed dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 1999;43:971-6.
7. Fowler JF, Van Limbergen EF. Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 1997;37:877-83.
8. Freel JH, Speiser BL. Pulsed low dose rate brachytherapy for uterine cervix carcinoma. Int J Radiat Oncol Biol Phys 1999;43:95-100.
9. Fritz P, Berns C, Anton HW, et al. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy. Radiother Oncol 1997;45:23-32.
10. Fritz P, Frank C, Weber KJ. In-vitro-Untersuchungen zur PDR-Brachytherapie. Strahlenther Onkol 1998;174:365-74.
11. Geiger M, Strnad V, Lotter M, et al. Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer. Brachytherapy 2002;1:149-53.
12. Hall EJ, Brenner DJ. Pulsed dose-rate brachytherapy [Editorial, Comment]. Radiother Oncol 1997;45:1-2.
13. Harms W, Peschke P, Weber KJ, et al. Dose-dependent differential effects of low and pulsed dose-rate brachytherapy in a radioresistant syngenic rat prostate tumour model. Int J Radiat Biol 2002;78:617-23.
14. Housset M, Baillet F, Dessard-Diana B, et al. A retrospective analysis of three treatment techniques for T1-2 base of tongue lesions: surgery plus postoperative irradiation, external irradiation plus interstitial implantation and external irradiation alone. Int J Radiat Oncol Biol Phys 1987;13:511-6.
15. Jensen PT, Roed H, Engelholm SA, et al. Pulsed dose rate (PDR) brachytherapy as salvage treatment of locally advanced or recurrent gynecologic cancer. Int J Radiat Oncol Biol Phys 1998;42:1041-7.
16. Lapeyre M, Bollet MA, Racadot S, et al. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head Neck 2004;26:216-23.
17. Lartigau E. Is "pulse dose rate" curietherapy comparable to low dose rate brachytherapy? Bull Cancer Radiother 1995;82:336-9.
18. Levendag PC, Schmitz PI, Jansen PP, et al. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 1997:38:497-506.
19. Mason KA, Thames HD, Ochran TG, et al. Comparison of continuous and pulsed low dose rate brachytherapy: biological equivalence in vivo. Int J Radiat Oncol Biol Phys 1994;28:667-71.
20. Mazeron JJ, Grimard L, Raynal M, et al. Iridium-192 curietherapy for T1 and T2 epidermoid carcinomas of the floor of mouth. Int J Radiat Oncol Biol Phys 1990;18:1299-306.
21. Mazeron JJ, Noel G, Simon JM. Head and neck brachytherapy. Semin Radiat Oncol 2002;12:95-108.
22. Mazeron JJ, Simon JM, Le Pechoux C, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol 1991;21:39-47.
23. Mendenhall WM, Parsons JT, Stringer SP. Radiotherapy after excisional biopsy of carcinoma of the oral tongue/floor of the mouth. Head Neck 1989;11:129-31.
24. Niedbala M, Alsbeih G, Ng CE, et al. Equivalence of pulsed-dose-rate to low-dose-rate irradiation in tumor and normal cell lines. Radiat Res 2001;155:297-303.
25. Nose T, Peiffert D, Lapeyre M, et al. Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate? Strahlenther Onkol 2004;180:776-82.
26. Peiffert D, Castelain B, Thomas L, et al. Pulsed dose rate brachytherapy in head and neck cancers. Feasibility study of a French cooperative group. Radiother Oncol 2001;58:71-5.
27. Pernot M, Hoffstetter S, Peiffert D, et al. Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases. Radiother Oncol 1995;35:177-85.
28. Pernot M, Hoffstetter S, Peiffert D, et al. Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: reflection of a series of 1344 patients treated at the time of initial presentation. Otolaryngol Head Neck Surg 1996;115:519-26.
29. Pop LA, van den Broek JF, Visser AG, et al. Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy. Radiother Oncol 1996;38:153-62.
30. Roed H, Engelholm SA, Svendsen LB, et al. Pulsed dose rate (PDR) brachytherapy of anal carcinoma. Radiother Oncol 1996;41:131-4.
31. Rogers CL, Freel JH, Speiser BL. Pulsed low dose rate brachytherapy for uterine cervix carcinoma. Int J Radiat Oncol Biol Phys 1999;43:95-100.
32. Sethi T, Dixon B, Flynn A, et al. Continuous, pulsed or single acute irradiation of a transplanted rodent tumour model. Radiother Oncol 1997;43:203-9.
33. Simon JM, Mazeron JJ, Pohar S, et al. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth. Radiother Oncol 1993;26:19-25.
34. Skowronek J, Piotrowski T. Pulsed dose rate brachytherapy: a method, description and review of clinical application. Przegl Lek 2002;59:31-6.
35. Sminia P, Schneider CJ, van Tienhoven G, et al. Office hours pulsed brachytherapy boost in breast cancer. Radiother Oncol 2001;59:273-80.
36. Strnad V. Treatment of oral cavity and oropharyngeal cancer: indications, technical aspects, and results of interstitial brachytherapy. Strahlenther Onkol 2004;180:710-7.
37. Strnad V, Geiger M, Lotter M, et al. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Brachytherapy 2003;2:158-63.
38. Strnad V, Jacobs H. Head and neck cancer. In: Strnad V, Pötter R, Kovács G, eds. State and prospects of clinical brachytherapy. Bremen-London-Boston: UNI-MED, 2004:142-53.
39. Strnad V, Lotter M, Grabenbauer G, et al. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery. Int J Radiat Oncol Biol Phys 2000;46:27-30.
40. Swift PS, Purser P, Roberts LW, et al. Pulsed low dose rate brachytherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys 1997;37:811-7.
41. Takacsi-Nagy Z, Polgar C, Oberna F, et al. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma. Strahlenther Onkol 2004;180:768-75.
42. Visser AG, van den Aardweg GJ, Levendag PC. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments. Int J Radiat Oncol Biol Phys 1996;34:497-505.
43. Zienkiewicz J, Ziemlewski A, Serkies K, et al. Preliminary experiences in the treatment of head and neck neoplasms with the use of pulsed brachytherapy. Wiad Lek 2002;55:569-74.